Skip to content

Role of Homoeopathy in the Treatment of Generalised Anxiety Disorder

Usefulness of Individualized Homoeopathic Medicine in the Management of Generalized Anxiety Disorder by using Neuro Feedback Therapy - A Double Arm Comparative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042553
Enrollment
62
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Homoeopathic Medicine in Group A : Homoeopathic MEdicine in Group A Placebo in Group B Neurofeedback Therapy in both Groups Route of administration- Oral Globules Form. Pill Size 30 Fol

Sponsors

Bakson Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects diagnosed with Generalized Anxiety Disorder according to the diagnostic criteria given in DSM â?? V. 2. Age group: 18- 44 years 3. Sex: both male and female 4. Follow up of atleast 3 months will be considered in the study. 5. Who agreed to give consent for the study

Exclusion criteria

Exclusion criteria: 1. Subjects with other anxiety disorders. (namely panic disorder with and without agoraphobia, specific phobia, social phobia, obsessive â?? compulsive disorder and post â?? traumatic stress disorder) 2. Subjects with another psychiatric condition like depression, schizophrenia, delusional disorder, bipolar disorder. 3. Anxiety attributable to physiological effects of a substance (e.g. a drug of abuse, medication.) 4. Patients with suicidal tendencies. Suffering in other systemic disorder 5. Lactating and pregnant women

Design outcomes

Primary

MeasureTime frame
Symptomatic score changed on HAM-A scale towards improvement. Frequency and amplitude of α and β waves showed changes towards improvement Frequency and amplitude of α and β waves showed changes towards improvement Timepoint: Baseline, 2 weeks, 4 weeks for 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Vishal Singh Chauhan

Bakson Homoeopathic Medical College & Hospital

srivastavarimi8@gmail.com9592683249

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026